BAZ2A_HUMAN - dbPTM
BAZ2A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BAZ2A_HUMAN
UniProt AC Q9UIF9
Protein Name Bromodomain adjacent to zinc finger domain protein 2A
Gene Name BAZ2A
Organism Homo sapiens (Human).
Sequence Length 1905
Subcellular Localization Nucleus, nucleolus. Colocalizes with the basal RNA polymerase I transcription factor UBF in the nucleolus..
Protein Description Essential component of the NoRC (nucleolar remodeling complex) complex, a complex that mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing. In the complex, it plays a central role by being recruited to rDNA and by targeting chromatin modifying enzymes such as HDAC1, leading to repress RNA polymerase I transcription. Recruited to rDNA via its interaction with TTF1 and its ability to recognize and bind histone H4 acetylated on 'Lys-16' (H4K16ac), leading to deacetylation of H4K5ac, H4K8ac, H4K12ac but not H4K16ac. Specifically binds pRNAs, 150-250 nucleotide RNAs that are complementary in sequence to the rDNA promoter; pRNA-binding is required for heterochromatin formation and rDNA silencing (By similarity)..
Protein Sequence MEMEANDHFNFTGLPPAPAASGLKPSPSSGEGLYTNGSPMNFPQQGKSLNGDVNVNGLSTVSHTTTSGILNSAPHSSSTSHLHHPSVAYDCLWNYSQYPSANPGSNLKDPPLLSQFSGGQYPLNGILGGSRQPSSPSHNTNLRAGSQEFWANGTQSPMGLNFDSQELYDSFPDQNFEVMPNGPPSFFTSPQTSPMLGSSIQTFAPSQEVGSGIHPDEAAEKEMTSVVAENGTGLVGSLELEEEQPELKMCGYNGSVPSVESLHQEVSVLVPDPTVSCLDDPSHLPDQLEDTPILSEDSLEPFNSLAPEPVSGGLYGIDDTELMGAEDKLPLEDSPVISALDCPSLNNATAFSLLADDSQTSTSIFASPTSPPVLGESVLQDNSFDLNNGSDAEQEEMETQSSDFPPSLTQPAPDQSSTIQLHPATSPAVSPTTSPAVSLVVSPAASPEISPEVCPAASTVVSPAVFSVVSPASSAVLPAVSLEVPLTASVTSPKASPVTSPAAAFPTASPANKDVSSFLETTADVEEITGEGLTASGSGDVMRRRIATPEEVRLPLQHGWRREVRIKKGSHRWQGETWYYGPCGKRMKQFPEVIKYLSRNVVHSVRREHFSFSPRMPVGDFFEERDTPEGLQWVQLSAEEIPSRIQAITGKRGRPRNTEKAKTKEVPKVKRGRGRPPKVKITELLNKTDNRPLKKLEAQETLNEEDKAKIAKSKKKMRQKVQRGECQTTIQGQARNKRKQETKSLKQKEAKKKSKAEKEKGKTKQEKLKEKVKREKKEKVKMKEKEEVTKAKPACKADKTLATQRRLEERQRQQMILEEMKKPTEDMCLTDHQPLPDFSRVPGLTLPSGAFSDCLTIVEFLHSFGKVLGFDPAKDVPSLGVLQEGLLCQGDSLGEVQDLLVRLLKAALHDPGFPSYCQSLKILGEKVSEIPLTRDNVSEILRCFLMAYGVEPALCDRLRTQPFQAQPPQQKAAVLAFLVHELNGSTLIINEIDKTLESMSSYRKNKWIVEGRLRRLKTVLAKRTGRSEVEMEGPEECLGRRRSSRIMEETSGMEEEEEEESIAAVPGRRGRRDGEVDATASSIPELERQIEKLSKRQLFFRKKLLHSSQMLRAVSLGQDRYRRRYWVLPYLAGIFVEGTEGNLVPEEVIKKETDSLKVAAHASLNPALFSMKMELAGSNTTASSPARARGRPRKTKPGSMQPRHLKSPVRGQDSEQPQAQLQPEAQLHAPAQPQPQLQLQLQSHKGFLEQEGSPLSLGQSQHDLSQSAFLSWLSQTQSHSSLLSSSVLTPDSSPGKLDPAPSQPPEEPEPDEAESSPDPQALWFNISAQMPCNAAPTPPPAVSEDQPTPSPQQLASSKPMNRPSAANPCSPVQFSSTPLAGLAPKRRAGDPGEMPQSPTGLGQPKRRGRPPSKFFKQMEQRYLTQLTAQPVPPEMCSGWWWIRDPEMLDAMLKALHPRGIREKALHKHLNKHRDFLQEVCLRPSADPIFEPRQLPAFQEGIMSWSPKEKTYETDLAVLQWVEELEQRVIMSDLQIRGWTCPSPDSTREDLAYCEHLSDSQEDITWRGRGREGLAPQRKTTNPLDLAVMRLAALEQNVERRYLREPLWPTHEVVLEKALLSTPNGAPEGTTTEISYEITPRIRVWRQTLERCRSAAQVCLCLGQLERSIAWEKSVNKVTCLVCRKGDNDEFLLLCDGCDRGCHIYCHRPKMEAVPEGDWFCTVCLAQQVEGEFTQKPGFPKRGQKRKSGYSLNFSEGDGRRRRVLLRGRESPAAGPRYSEEGLSPSKRRRLSMRNHHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFYQGKQANL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
21PhosphorylationLPPAPAASGLKPSPS
CCCCCCCCCCCCCCC
46.9226074081
26PhosphorylationAASGLKPSPSSGEGL
CCCCCCCCCCCCCCC
35.5126074081
28PhosphorylationSGLKPSPSSGEGLYT
CCCCCCCCCCCCCCC
56.1426074081
29PhosphorylationGLKPSPSSGEGLYTN
CCCCCCCCCCCCCCC
44.2226074081
34PhosphorylationPSSGEGLYTNGSPMN
CCCCCCCCCCCCCCC
14.7126074081
35PhosphorylationSSGEGLYTNGSPMNF
CCCCCCCCCCCCCCC
37.8425627689
38PhosphorylationEGLYTNGSPMNFPQQ
CCCCCCCCCCCCCCC
24.0525159151
67PhosphorylationTVSHTTTSGILNSAP
ECEEECCCCHHHCCC
23.03-
114PhosphorylationLKDPPLLSQFSGGQY
CCCCCHHHHCCCCCC
36.5423090842
117PhosphorylationPPLLSQFSGGQYPLN
CCHHHHCCCCCCCCC
34.0823090842
121PhosphorylationSQFSGGQYPLNGILG
HHCCCCCCCCCCCCC
16.9823090842
130PhosphorylationLNGILGGSRQPSSPS
CCCCCCCCCCCCCCC
26.4123090842
134PhosphorylationLGGSRQPSSPSHNTN
CCCCCCCCCCCCCCC
46.6830266825
135PhosphorylationGGSRQPSSPSHNTNL
CCCCCCCCCCCCCCC
36.7923401153
137PhosphorylationSRQPSSPSHNTNLRA
CCCCCCCCCCCCCCC
31.1730266825
137 (in isoform 2)Phosphorylation-31.1721406692
138 (in isoform 2)Phosphorylation-48.8221406692
140PhosphorylationPSSPSHNTNLRAGSQ
CCCCCCCCCCCCCCC
30.1523403867
154PhosphorylationQEFWANGTQSPMGLN
CCHHHCCCCCCCCCC
26.1926074081
156PhosphorylationFWANGTQSPMGLNFD
HHHCCCCCCCCCCCC
19.3826074081
311PhosphorylationSLAPEPVSGGLYGID
HCCCCCCCCCCCCCC
37.5526074081
315PhosphorylationEPVSGGLYGIDDTEL
CCCCCCCCCCCHHHC
18.4726074081
352PhosphorylationLNNATAFSLLADDSQ
CCCHHHHHHHCCCCC
21.7326074081
358PhosphorylationFSLLADDSQTSTSIF
HHHHCCCCCCCCCEE
35.5926074081
360PhosphorylationLLADDSQTSTSIFAS
HHCCCCCCCCCEECC
37.6126074081
361PhosphorylationLADDSQTSTSIFASP
HCCCCCCCCCEECCC
16.7226074081
367PhosphorylationTSTSIFASPTSPPVL
CCCCEECCCCCCCCC
20.2626074081
369PhosphorylationTSIFASPTSPPVLGE
CCEECCCCCCCCCCC
51.9026074081
370PhosphorylationSIFASPTSPPVLGES
CEECCCCCCCCCCCC
30.5026074081
469PhosphorylationSPAVFSVVSPASSAV
CCHHHCCCCCCCCCC
5.7015302935
473 (in isoform 2)Phosphorylation-23.3921406692
480 (in isoform 2)Phosphorylation-6.7421406692
482 (in isoform 2)Phosphorylation-6.5521406692
487PhosphorylationVSLEVPLTASVTSPK
EEEEEEEEEEECCCC
15.7126074081
489PhosphorylationLEVPLTASVTSPKAS
EEEEEEEEECCCCCC
22.2326074081
491PhosphorylationVPLTASVTSPKASPV
EEEEEEECCCCCCCC
36.5026074081
492PhosphorylationPLTASVTSPKASPVT
EEEEEECCCCCCCCC
23.4226074081
494PhosphorylationTASVTSPKASPVTSP
EEEECCCCCCCCCCC
62.3518669648
496PhosphorylationSVTSPKASPVTSPAA
EECCCCCCCCCCCCH
26.4830266825
499PhosphorylationSPKASPVTSPAAAFP
CCCCCCCCCCCHHCC
32.1730266825
500O-linked_GlycosylationPKASPVTSPAAAFPT
CCCCCCCCCCHHCCC
16.8730379171
500PhosphorylationPKASPVTSPAAAFPT
CCCCCCCCCCHHCCC
16.8730266825
507PhosphorylationSPAAAFPTASPANKD
CCCHHCCCCCCCCCC
33.0630266825
509PhosphorylationAAAFPTASPANKDVS
CHHCCCCCCCCCCHH
27.3330266825
513AcetylationPTASPANKDVSSFLE
CCCCCCCCCHHHHHH
62.7126051181
516PhosphorylationSPANKDVSSFLETTA
CCCCCCHHHHHHHCC
26.0426074081
517PhosphorylationPANKDVSSFLETTAD
CCCCCHHHHHHHCCC
33.4326074081
521PhosphorylationDVSSFLETTADVEEI
CHHHHHHHCCCHHHH
29.4518669648
548O-linked_GlycosylationVMRRRIATPEEVRLP
HHHCCCCCHHHCCCC
28.9430379171
548PhosphorylationVMRRRIATPEEVRLP
HHHCCCCCHHHCCCC
28.9430266825
568UbiquitinationRREVRIKKGSHRWQG
EEEEEEECCCCCCCC
64.37-
585AcetylationWYYGPCGKRMKQFPE
EEECCCCHHHHHHHH
56.9126051181
585MethylationWYYGPCGKRMKQFPE
EEECCCCHHHHHHHH
56.91-
595UbiquitinationKQFPEVIKYLSRNVV
HHHHHHHHHHHHHHH
45.3621906983
604PhosphorylationLSRNVVHSVRREHFS
HHHHHHHHHHHHHCC
13.00-
611PhosphorylationSVRREHFSFSPRMPV
HHHHHHCCCCCCCCC
27.0722617229
613PhosphorylationRREHFSFSPRMPVGD
HHHHCCCCCCCCCHH
15.4826055452
649PhosphorylationPSRIQAITGKRGRPR
CHHHHHHHCCCCCCC
39.40-
651AcetylationRIQAITGKRGRPRNT
HHHHHHCCCCCCCCC
42.9225953088
680AcetylationRGRPPKVKITELLNK
CCCCCCCCHHHHCCC
50.4619578370
687AcetylationKITELLNKTDNRPLK
CHHHHCCCCCCCCCH
58.1723236377
688PhosphorylationITELLNKTDNRPLKK
HHHHCCCCCCCCCHH
37.1228555341
695SumoylationTDNRPLKKLEAQETL
CCCCCCHHHHHHHHC
60.28-
695SumoylationTDNRPLKKLEAQETL
CCCCCCHHHHHHHHC
60.28-
701PhosphorylationKKLEAQETLNEEDKA
HHHHHHHHCCHHHHH
23.8524173317
707AcetylationETLNEEDKAKIAKSK
HHCCHHHHHHHHHHH
55.6623236377
737AcetylationIQGQARNKRKQETKS
HHHHHHHHHHHHHHH
56.257367297
739AcetylationGQARNKRKQETKSLK
HHHHHHHHHHHHHHH
54.847367309
742O-linked_GlycosylationRNKRKQETKSLKQKE
HHHHHHHHHHHHHHH
24.3630379171
767AcetylationKGKTKQEKLKEKVKR
HCCHHHHHHHHHHHH
63.477258197
799AcetylationKPACKADKTLATQRR
CHHCHHCHHHHHHHH
50.7425953088
800PhosphorylationPACKADKTLATQRRL
HHCHHCHHHHHHHHH
23.3629759185
803PhosphorylationKADKTLATQRRLEER
HHCHHHHHHHHHHHH
26.2229759185
866SumoylationEFLHSFGKVLGFDPA
HHHHHHHHHHCCCCC
32.0728112733
921AcetylationPSYCQSLKILGEKVS
HHHHHHHHHHCCCCC
40.9226051181
928PhosphorylationKILGEKVSEIPLTRD
HHHCCCCCCCCCCCC
40.6621406692
995PhosphorylationIINEIDKTLESMSSY
EEHHHHHHHHHHHHH
31.82-
1006AcetylationMSSYRKNKWIVEGRL
HHHHHCCCHHHHHHH
41.1325953088
1023 (in isoform 2)Phosphorylation-36.4821406692
1024PhosphorylationKTVLAKRTGRSEVEM
HHHHHHHHCCCCCEE
35.9221712546
1024 (in isoform 2)Phosphorylation-35.9221406692
1027PhosphorylationLAKRTGRSEVEMEGP
HHHHHCCCCCEECCH
47.5421712546
1043PhosphorylationECLGRRRSSRIMEET
HHHCCHHHHHHHHHC
23.35-
1044PhosphorylationCLGRRRSSRIMEETS
HHCCHHHHHHHHHCC
24.82-
1050PhosphorylationSSRIMEETSGMEEEE
HHHHHHHCCCCCHHH
19.7830266825
1051PhosphorylationSRIMEETSGMEEEEE
HHHHHHCCCCCHHHH
39.1523401153
1061PhosphorylationEEEEEEESIAAVPGR
CHHHHHHHHCCCCCC
22.3230278072
1125PhosphorylationQDRYRRRYWVLPYLA
CHHHHHHHCHHHHHE
9.6921118733
1130PhosphorylationRRYWVLPYLAGIFVE
HHHCHHHHHEEEEEE
12.6721118733
1150SumoylationLVPEEVIKKETDSLK
CCCHHHHHHCCCCHH
50.1328112733
1163PhosphorylationLKVAAHASLNPALFS
HHHHHHHHCCHHHHH
20.8628111955
1170PhosphorylationSLNPALFSMKMELAG
HCCHHHHHHHEECCC
20.5324719451
1172SumoylationNPALFSMKMELAGSN
CHHHHHHHEECCCCC
28.20-
1172SumoylationNPALFSMKMELAGSN
CHHHHHHHEECCCCC
28.2028112733
1178PhosphorylationMKMELAGSNTTASSP
HHEECCCCCCCCCCC
25.9523403867
1180PhosphorylationMELAGSNTTASSPAR
EECCCCCCCCCCCHH
25.9923403867
1180 (in isoform 2)Phosphorylation-25.9921406692
1181PhosphorylationELAGSNTTASSPARA
ECCCCCCCCCCCHHH
28.8823403867
1183PhosphorylationAGSNTTASSPARARG
CCCCCCCCCCHHHCC
34.4630266825
1184PhosphorylationGSNTTASSPARARGR
CCCCCCCCCHHHCCC
21.8130266825
1195PhosphorylationARGRPRKTKPGSMQP
HCCCCCCCCCCCCCC
43.6923828894
1207PhosphorylationMQPRHLKSPVRGQDS
CCCCCCCCCCCCCCC
34.6830266825
1210MethylationRHLKSPVRGQDSEQP
CCCCCCCCCCCCCCC
40.20-
1214PhosphorylationSPVRGQDSEQPQAQL
CCCCCCCCCCCCHHC
30.1830576142
1243PhosphorylationQLQLQLQSHKGFLEQ
CHHHHHHHHCCHHHC
35.4424144214
1343PhosphorylationPTPPPAVSEDQPTPS
CCCCCCCCCCCCCCC
37.2518669648
1350PhosphorylationSEDQPTPSPQQLASS
CCCCCCCCHHHHHCC
37.5126657352
1364PhosphorylationSKPMNRPSAANPCSP
CCCCCCCCCCCCCCC
36.4530576142
1370PhosphorylationPSAANPCSPVQFSST
CCCCCCCCCCCCCCC
29.3925159151
1370 (in isoform 2)Phosphorylation-29.3921406692
1372 (in isoform 2)Phosphorylation-5.2921406692
1375PhosphorylationPCSPVQFSSTPLAGL
CCCCCCCCCCCCCCC
19.0622199227
1376PhosphorylationCSPVQFSSTPLAGLA
CCCCCCCCCCCCCCC
35.0222199227
1377PhosphorylationSPVQFSSTPLAGLAP
CCCCCCCCCCCCCCC
22.5630576142
1397PhosphorylationDPGEMPQSPTGLGQP
CCCCCCCCCCCCCCC
20.6829255136
1399PhosphorylationGEMPQSPTGLGQPKR
CCCCCCCCCCCCCCC
50.7329255136
1467UbiquitinationIREKALHKHLNKHRD
HHHHHHHHHHHHCHH
51.11-
1503PhosphorylationAFQEGIMSWSPKEKT
HHHHCCCCCCCCCCC
23.6028348404
1505PhosphorylationQEGIMSWSPKEKTYE
HHCCCCCCCCCCCHH
20.8427050516
1531PhosphorylationLEQRVIMSDLQIRGW
HHHHHHHCCCEECCE
24.8420068231
1532PhosphorylationEQRVIMSDLQIRGWT
HHHHHHCCCEECCEE
25.8017525332
1539PhosphorylationDLQIRGWTCPSPDST
CCEECCEECCCCCCC
19.8430266825
1542PhosphorylationIRGWTCPSPDSTRED
ECCEECCCCCCCHHH
43.4130266825
1545PhosphorylationWTCPSPDSTREDLAY
EECCCCCCCHHHHHH
32.5223663014
1546PhosphorylationTCPSPDSTREDLAYC
ECCCCCCCHHHHHHC
45.5223663014
1552PhosphorylationSTREDLAYCEHLSDS
CCHHHHHHCCCCCCC
12.9830266825
1557PhosphorylationLAYCEHLSDSQEDIT
HHHCCCCCCCCCCCC
36.8030266825
1559PhosphorylationYCEHLSDSQEDITWR
HCCCCCCCCCCCCCC
31.9017525332
1564PhosphorylationSDSQEDITWRGRGRE
CCCCCCCCCCCCCCC
22.7930108239
1579PhosphorylationGLAPQRKTTNPLDLA
CCCCCCCCCCHHHHH
33.7120068231
1580PhosphorylationLAPQRKTTNPLDLAV
CCCCCCCCCHHHHHH
37.5620068231
1620PhosphorylationVLEKALLSTPNGAPE
HHHHHHHCCCCCCCC
42.5427050516
1621PhosphorylationLEKALLSTPNGAPEG
HHHHHHCCCCCCCCC
22.2722199227
1629PhosphorylationPNGAPEGTTTEISYE
CCCCCCCCCEEEEEE
28.9622199227
1630PhosphorylationNGAPEGTTTEISYEI
CCCCCCCCEEEEEEE
33.0322199227
1631PhosphorylationGAPEGTTTEISYEIT
CCCCCCCEEEEEEEC
31.0326714015
1634PhosphorylationEGTTTEISYEITPRI
CCCCEEEEEEECHHH
15.5220068231
1635PhosphorylationGTTTEISYEITPRIR
CCCEEEEEEECHHHH
19.6020068231
1672UbiquitinationERSIAWEKSVNKVTC
HHHHHHHHCCCEEEE
49.34-
1672 (in isoform 3)Ubiquitination-49.3421890473
1676SumoylationAWEKSVNKVTCLVCR
HHHHCCCEEEEEEEE
36.4428112733
1676UbiquitinationAWEKSVNKVTCLVCR
HHHHCCCEEEEEEEE
36.4421890473
1676 (in isoform 1)Ubiquitination-36.4421890473
1709SumoylationHIYCHRPKMEAVPEG
EEEECCCCCCCCCCC
49.7028112733
1746AcetylationPKRGQKRKSGYSLNF
CCCCCCCCCCEECCC
56.0920167786
1747PhosphorylationKRGQKRKSGYSLNFS
CCCCCCCCCEECCCC
47.1725159151
1749PhosphorylationGQKRKSGYSLNFSEG
CCCCCCCEECCCCCC
19.6422199227
1750PhosphorylationQKRKSGYSLNFSEGD
CCCCCCEECCCCCCC
21.9925159151
1754PhosphorylationSGYSLNFSEGDGRRR
CCEECCCCCCCCCCE
39.3323403867
1756 (in isoform 2)Phosphorylation-41.2821406692
1758 (in isoform 2)Phosphorylation-35.5321406692
1768MethylationRRVLLRGRESPAAGP
EEEEECCCCCCCCCC
34.48-
1770PhosphorylationVLLRGRESPAAGPRY
EEECCCCCCCCCCCC
20.6230266825
1776MethylationESPAAGPRYSEEGLS
CCCCCCCCCCCCCCC
46.84-
1777PhosphorylationSPAAGPRYSEEGLSP
CCCCCCCCCCCCCCH
24.4623927012
1778PhosphorylationPAAGPRYSEEGLSPS
CCCCCCCCCCCCCHH
30.3723927012
1783PhosphorylationRYSEEGLSPSKRRRL
CCCCCCCCHHHHHHH
37.6729255136
1785PhosphorylationSEEGLSPSKRRRLSM
CCCCCCHHHHHHHHC
35.1030266825
1786AcetylationEEGLSPSKRRRLSMR
CCCCCHHHHHHHHCC
53.9925953088
1786UbiquitinationEEGLSPSKRRRLSMR
CCCCCHHHHHHHHCC
53.99-
1787MethylationEGLSPSKRRRLSMRN
CCCCHHHHHHHHCCH
33.03-
1841PhosphorylationIKNPMDFSTMRERLL
HCCCCCHHHHHHHHH
19.6123403867
1842PhosphorylationKNPMDFSTMRERLLR
CCCCCHHHHHHHHHC
21.9023403867
1901UbiquitinationWEEFYQGKQANL---
HHHHHCHHHCCC---
30.6121906983

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
509SPhosphorylationKinaseCDK2P24941
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
680KAcetylation

19578370

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BAZ2A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SMCA5_HUMANSMARCA5physical
11532953
KAT8_HUMANKAT8physical
19578370
SMCA5_HUMANSMARCA5physical
19578370
HDAC1_HUMANHDAC1physical
16085498
DNMT1_HUMANDNMT1physical
16085498
DNM3B_HUMANDNMT3Bphysical
16085498
SMCA5_HUMANSMARCA5physical
16085498
BEND3_HUMANBEND3physical
26100909
UBP21_HUMANUSP21physical
26100909

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BAZ2A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Reversible acetylation of the chromatin remodelling complex NoRC isrequired for non-coding RNA-dependent silencing.";
Zhou Y., Schmitz K.M., Mayer C., Yuan X., Akhtar A., Grummt I.;
Nat. Cell Biol. 11:1010-1016(2009).
Cited for: ACETYLATION AT LYS-680.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1050; SER-1051; SER-1397AND SER-1783, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-509; SER-1184; SER-1397AND SER-1783, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-548; SER-1747; SER-1770;SER-1778 AND SER-1783, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1397, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-548 AND SER-1747, ANDMASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1559, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1397, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-496, AND MASSSPECTROMETRY.

TOP